Figure 4
Figure 4. Splenic DCs from LPS-treated but not naive Daf−/− mice are more potent T-cell stimulators than similarly treated WT DCs. (A) FACS analysis (left panel) showing that splenic DCs from naive WT but not Daf−/− mice expressed DAF. There was no difference between splenic DCs from naive WT and Daf−/− mice in their ability to stimulate OT-II CD4+ or OT-I CD8+ T cells, as measured by IFN-γ production (right panel). NS indicates not significant. P > .05. (B) FACS analysis (left panel) showing that splenic DCs from LPS-treated WT but not Daf−/− mice expressed DAF. DCs from LPS-treated Daf−/− mice were more potent than similarly harvested WT mouse DCs in stimulating OT-II CD4+ or OT-I CD8+ T cells, as measured by IFN-γ production. *P < .05. All data are representative of 3 independent experiments.

Splenic DCs from LPS-treated but not naive Daf−/− mice are more potent T-cell stimulators than similarly treated WT DCs. (A) FACS analysis (left panel) showing that splenic DCs from naive WT but not Daf−/− mice expressed DAF. There was no difference between splenic DCs from naive WT and Daf−/− mice in their ability to stimulate OT-II CD4+ or OT-I CD8+ T cells, as measured by IFN-γ production (right panel). NS indicates not significant. P > .05. (B) FACS analysis (left panel) showing that splenic DCs from LPS-treated WT but not Daf−/− mice expressed DAF. DCs from LPS-treated Daf−/− mice were more potent than similarly harvested WT mouse DCs in stimulating OT-II CD4+ or OT-I CD8+ T cells, as measured by IFN-γ production. *P < .05. All data are representative of 3 independent experiments.

Close Modal

or Create an Account

Close Modal
Close Modal